Year Ended December 31, | |||
2020 | 2019 | 2018 | |
(In thousands) | |||
Cash flows from operating activities: | |||
Net income attributable to Ebix, Inc. | $92,377 | $96,720 | $93,139 |
Net (loss) income attributable to noncontrolling interest | (3,550) | (6,149) | (58) |
Adjustments to reconcile net income to cash provided by operating activities: | |||
Depreciation and amortization | 13,738 | 14,468 | 11,292 |
Provision for doubtful accounts | 1,749 | 12,325 | 3,571 |
Provision for deferred taxes, net of acquisitions and effects of currency translation | 5,114 | (15,525) | (13,043) |
Unrealized foreign exchange losses | — | 1,104 | 606 |
Amortization of right-of-use assets | 6,100 | 7,144 | — |
Amortization of capitalized software development costs | 3,367 | 2,696 | 2,233 |
Share-based compensation | 4,792 | 3,397 | 2,811 |
Reduction of acquisition earn-out contingent liability | (3,105) | (16,543) | (1,391) |
Cash paid for acquisition earn-out | (6,453) | — | (3,831) |
Intangible asset impairment | 6,168 | — | — |
Changes in current assets and liabilities, net of acquisitions: | |||
Accounts receivable | 3,258 | (22,977) | 15,839 |
Receivables from service providers | 20,896 | 10,950 | (36,557) |
Payables to service agents | (6,915) | (13,455) | 25,651 |
Other assets | (10,487) | (8,351) | (8,486) |
Accounts payable and accrued expenses | (14,569) | (19,624) | (11,787) |
Accrued payroll and related benefits | 2,100 | (661) | (788) |
Lease liabilities | (5,700) | (6,878) | (360) |
Reserve for potential uncertain income tax return positions | — | (95) | 149 |
Other liabilities | (12,204) | 30,396 | 13,205 |
Contract liabilities | 3,680 | (8,149) | (8,740) |
Net cash provided by operating activities | 100,356 | 60,793 | 83,455 |
Cash flows from investing activities: | |||
Cash paid for acquisitions, net of cash acquired | (14,276) | (105,466) | (232,557) |
Cash (paid to) received from Paul Merchants for 10% stake in MTSS combined business and other investment | — | (5,348) | 4,996 |
Maturities (purchases) of marketable securities | (20,964) | 27,015 | (4,087) |
Capitalized software development costs | (4,229) | (7,989) | (8,079) |
Capital expenditures | (5,337) | (4,908) | (8,032) |
Net cash used in investing activities | (44,806) | (96,696) | (247,759) |
Cash flows from financing activities: | |||
Proceeds from / (payment) to revolving line of credit, net | 1,364 | 13,500 | 150,008 |
Proceeds from term loan | — | — | 175,500 |
Principal payments on term loan obligation | (20,711) | (15,063) | (10,016) |
Payments on short-term notes, net | — | 6,450 | (8,341) |
Working capital facilities | (10,927) | 19,079 | (8,094) |
Repurchase of common stock | — | (12,952) | (40,820) |
Payments of long term debt | (271) | (686) | (80) |
Payments for capital lease obligations | (210) | — | (6) |
Proceeds from exercise of common stock options | 636 | — | 439 |
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested | (2,589) | (230) | (467) |
Dividends paid | (9,245) | (9,193) | (9,316) |
Net cash (used) provided by financing activities | (41,953) | 905 | 248,807 |
Effect of foreign exchange rates on cash and cash equivalents | (4,753) | (3,314) | (5,689) |
Net change in cash and cash equivalents, and restricted cash | 8,844 | (38,312) | 78,814 |
Cash and cash equivalents, and restricted cash at the beginning of the year | 111,369 | 149,681 | 70,867 |
Cash and cash equivalents, and restricted cash at the end of the year | $120,213 | $111,369 | $149,681 |
Supplemental disclosures of cash flow information: | |||
Interest paid | 29,498 | 41,143 | 25,690 |
Income taxes paid | 21,321 | 24,041 | 10,149 |
Thank You for contacting us. Someone from the RCS team will be contacting you soon.
You are already subscribed for email alerts.
You may automatically receive Ebix, Inc.’s financial information by email. Please enter your contact details for email notifications below and click "Submit"
Link for this page has been sent to the recipient along with your message.
Thank you for visiting Ebix web site. To send this page link directly to a friend or colleague, complete the form below.
Copyright © 2022 Ebix Inc. Terms Of Use | Privacy Statement
This website is best viewed in ie9+, Firefox, Google Chrome, Opera and on all latest browsers.